Physician profile

Melody Vasquez

Nurse Practitioner · Brunswick, GA

NPI 1184257560

$12,692.19

in general payments reported to CMS, 2019-2025

48 companies · $2,773 in 2025

The $2,773 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).

See the full distribution for Nurse Practitioner

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,217.28
Education$325.97

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,877.68 2021-2025
Ucb, INC. $1,120.47 2023-2025 Cimzia, Bimzelx
Astrazeneca Pharmaceuticals LP $994.33 2021-2025 Saphnelo
Mallinckrodt Hospital Products INC. $955.75 2023-2025 Acthar
Amgen INC. $916.04 2021-2025 Evenity, Prolia, Krystexxa
Janssen Biotech, INC. $887.28 2023-2025 Tremfya, Remicade, Stelara
Sunovion Pharmaceuticals INC. $855.95 2021-2022
Pfizer INC. $602.88 2022-2025
Ani Pharmaceuticals, INC. $499.20 2023-2025 Purified Cortrophin Gel
Axsome Therapeutics, INC. $348.87 2023-2025 Auvelity
Boehringer Ingelheim Pharmaceuticals, INC. $319.15 2021-2024 Ofev
Glaxosmithkline, LLC. $283.09 2021-2025 Benlysta
Novo Nordisk INC $247.58 2021-2022
Genzyme Corporation $245.56 2024-2025
Sanofi-Aventis U.S. LLC $179.58 2021-2024
Show all 48 companies
CompanyGeneral paymentsYearsTop products
Lilly USA, LLC $167.00 2021-2024 Taltz
Merck Sharp & Dohme LLC $157.48 2021-2022
Biohaven Pharmaceutical Holding Company LTD. $155.98 2022
Organon LLC $144.33 2023-2025 Renflexis, Hadlima
Bayer Healthcare Pharmaceuticals INC. $142.02 2022
Horizon Therapeutics Plc $141.57 2023 Krystexxa
Azurity Pharmaceuticals, INC. $136.61 2023-2025 Horizant, Horizant
Radius Health, INC. $132.54 2023-2025
Janssen Pharmaceuticals, INC $126.76 2021-2022
Nestle Healthcare Nutrition INC. $113.67 2021-2022
Biohaven Pharmaceuticals, INC. $96.51 2021
Novartis Pharmaceuticals Corporation $88.79 2022-2025
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $80.56 2024-2025 Caplyta
Otsuka America Pharmaceutical, INC. $68.63 2022-2025 Rexulti
Genentech USA, INC. $64.87 2024-2025 Actemra
Aurinia Pharma U.S., INC. $57.59 2023-2025 Lupkynis
Dexcom, INC. $53.05 2021-2022
Astellas Pharma US INC $45.23 2021-2022
Actelion Pharmaceuticals US, INC. $44.29 2024 Opsumit
Neurocrine Biosciences, INC. $41.47 2021
Kiniksa Pharmaceuticals International, Plc $39.83 2024 Arcalyst
Vifor Pharma, INC. $31.83 2021
Mylan Specialty L.P. $29.40 2021-2022
Takeda Pharmaceuticals U.S.A., INC. $26.71 2024 Hyqvia
E.R. Squibb & Sons, L.L.C. $23.95 2024 Orencia
Fresenius Kabi USA, LLC $23.56 2025 Tyenne
Xeris Pharmaceuticals, INC. $22.53 2021
Kiniksa Pharmaceuticals, LTD. $22.09 2023 Arcalyst
Corcept Therapeutics $18.48 2021
Pacira Therapeutics, INC. $17.22 2021
Lundbeck LLC $16.90 2022
Impel Pharmaceuticals INC. $14.31 2022
Bioventus LLC $13.02 2023 Durolane

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Melody Vasquez

$12,692.19

in general payments reported 2019-2025

Years
2021-2025
Top company
Abbvie INC.
Context
The $2,773 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).

https://glasscript.com/doctor/10914892/melody-vasquez

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.